Nanofenretinide Websites

- scitech.ventures

SciTech Development - Clinical stage pharma company with strong clinical KOL backing that reformulated fenretinide, a safe & efficacious anticancer agent, into its patented nanoFenretinide IV drug yielding mandated bioavailability resulting in immune & chemo effects that safely produce apoptosis.

Not Applicable $ 8.95